Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$3.41M Buy
9,685
+409
+4% +$146K 0.02% 384
2025
Q4
$3.04M Buy
+9,276
New +$2.94M 0.01% 371
2025
Q1
Sell
-86,660
Closed -$22.6M 660
2024
Q4
$22.6M Sell
86,660
-60,774
-41% -$18M 0.11% 144
2024
Q3
$47.5M Sell
147,434
-1,550
-1% -$507K 0.24% 111
2024
Q2
$46.6M Buy
148,984
+57,707
+63% +$17M 0.26% 109
2024
Q1
$26M Buy
91,277
+80,705
+763% +$23.6M 0.14% 144
2023
Q4
$3.04M Sell
10,572
-1,389
-12% -$378K 0.02% 373
2023
Q3
$3.21M Buy
+11,961
New +$2.98M 0.02% 310
2023
Q2
Sell
-118,926
Closed -$28.8M 666
2023
Q1
$28.8M Buy
118,926
+10,966
+10% +$2.69M 0.2% 125
2022
Q4
$28.4M Buy
+107,960
New +$28.9M 0.21% 125

Other funds holding AMGN

AGF Management's AMGN Position: Q1 2026 in Review

AGF Management increased its Amgen (AMGN) stake by 4.4% in Q1 2026, buying an estimated $146K and bringing the position to 9,685 shares worth $3.41M. The position accounts for 0.02% of the portfolio, ranked #384.

AGF Management first reported a position in AMGN in Q4 2022 and has held it in 10 quarters since. The position peaked at $47.5M in Q3 2024. 3,126 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.

  • AGF Management held 9,685 shares of Amgen worth $3.41M as of Q1 2026.
  • AGF Management bought 409 Amgen shares in Q1 2026, an estimated $146K.
  • Amgen made up 0.02% of AGF Management's portfolio in Q1 2026, its #384 holding.
  • AGF Management first reported a position in Amgen in Q4 2022 and has held it in 10 quarters since.
  • AGF Management's Amgen position peaked at $47.5M in Q3 2024.
  • 3,126 funds tracked by Wall St. Rank held Amgen as of Q1 2026.

Based on AGF Management's 13F filing for Q1 2026, filed 7 May 2026.